Sign Up to like & get
recommendations!
0
Published in 2017 at "Investigational New Drugs"
DOI: 10.1007/s10637-017-0538-9
Abstract: SummaryPolymeric nanoparticles based on cyclodextrins are currently undergoing clinical trials as new promising nanotherapeutics. In light of this interest, we investigated cyclodextrin cross-linked polymers with different lengths as carriers for the poorly water-soluble drug sorafenib.…
read more here.
Keywords:
nanocarriers sorafenib;
cyclodextrin polymers;
sorafenib;
polymers nanocarriers ... See more keywords